Indegene's board will gather on April 29, 2026 to review the annual financial statements and decide on a potential dividend distribution. The trading window is currently closed from April 1, 2026, and will reopen only after the results are announced, which is approximately 48 hours later.

On April 1, 2026, Indegene Healthcare UK has acquired Trilogy Writing assets, valued at £190K, in a related-party deal, being subsidiaries of the parent company Indegene Ltd.